Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Coronary Artery Disease"" wg kryterium: Temat


Tytuł :
2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.
Autorzy :
Bakaeen FG; Department of Thoracic and Cardiovascular Surgery, Coronary Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: .
Gaudino M; Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY.
Whitman G; Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University, Baltimore, Md.
Doenst T; Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, University Hospital, Jena, Germany.
Ruel M; Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Taggart DP; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Stulak JM; Division of Cardiothoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn.
Benedetto U; Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.
Anyanwu A; Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
Chikwe J; Department of Cardiac Surgery, Smidt Heart Institute at Cedars-Sinai, Los Angeles, Calif.
Bozkurt B; Division of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Tex.
Puskas JD; Department of Cardiovascular Surgery, Mount Sinai Morningside Hospital, New York, NY.
Silvestry SC; AdventHealth Transplant Institute, Orlando, Fla.
Velazquez E; Department of Cardiovascular Medicine, Heart and Vascular Center, Yale New Haven Health, New Haven, Conn.
Slaughter MS; Department Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Ky.
McCarthy PM; Bluhm Cardiovascular Institute and Division of Cardiac Surgery in the Department of Surgery, Northwestern University, Chicago, Ill.
Soltesz EG; Department of Thoracic and Cardiovascular Surgery, Coronary Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
Moon MR; Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, Mo.
Pokaż więcej
Corporate Authors :
American Association for Thoracic Surgery Cardiac Clinical Practice Standards Committee
Invited Experts
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2021 Sep; Vol. 162 (3), pp. 829-850.e1. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Journal Article; Practice Guideline; Review
MeSH Terms :
Cardiology/*standards
Cardiomyopathies/*etiology
Coronary Artery Bypass/*standards
Coronary Artery Disease/*surgery
Heart Failure/*etiology
Cardiomyopathies/diagnostic imaging ; Cardiomyopathies/physiopathology ; Consensus ; Coronary Artery Bypass/adverse effects ; Coronary Artery Disease/complications ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/physiopathology ; Delphi Technique ; Heart Failure/diagnostic imaging ; Heart Failure/physiopathology ; Humans ; Postoperative Complications/etiology ; Risk Assessment ; Risk Factors ; Stroke Volume ; Treatment Outcome ; Ventricular Function, Left
Czasopismo naukowe
Tytuł :
Genome-Wide Association Study Identifies a Functional SIDT2 Variant Associated With HDL-C (High-Density Lipoprotein Cholesterol) Levels and Premature Coronary Artery Disease.
Autorzy :
León-Mimila P; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
Villamil-Ramírez H; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
Macías-Kauffer LR; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).; Dirección de Planeación, Enseñanza e Investigación, Hospital Regional de Alta Especialidad de Ixtapaluca, Estado de México (L.R.M.-K.).
Jacobo-Albavera L; Laboratorio de Enfermedades Cardiovasculares, INMEGEN, Mexico City (L.J.-A., M.D.-P., T.V.-M.).
López-Contreras BE; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
Posadas-Sánchez R; Departamento de Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City (R.P.-S., C.P.-R.).
Posadas-Romero C; Departamento de Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City (R.P.-S., C.P.-R.).
Romero-Hidalgo S; Departamento de Genómica Computacional, INMEGEN, Mexico City (S.R.-H.).
Morán-Ramos S; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).; Consejo Nacional de Ciencia y Tecnología (CONACyT), Mexico City (S.M.-R.).
Domínguez-Pérez M; Laboratorio de Enfermedades Cardiovasculares, INMEGEN, Mexico City (L.J.-A., M.D.-P., T.V.-M.).
Olivares-Arevalo M; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
López-Montoya P; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
Nieto-Guerra R; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
Acuña-Alonzo V; Escuela Nacional de Antropología e Historia, Mexico City (V.A.-A., G.M.-P.).
Macín-Pérez G; Escuela Nacional de Antropología e Historia, Mexico City (V.A.-A., G.M.-P.).
Barquera-Lozano R; Max Planck Institute for the Science of Human History, Jena, Germany (R.B.-L.).
Del-Río-Navarro BE; Hospital Infantil de México Federico Gómez, Mexico City (B.E.D.-R.-N.).
González-González I; Hospital General Rubén Leñero, Mexico City (I.G.-G., F.C.-P.).
Campos-Pérez F; Hospital General Rubén Leñero, Mexico City (I.G.-G., F.C.-P.).
Gómez-Pérez F; Unidad de Investigación en Enfermedades Metabólicas and Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (F.G.-P., C.A.A.-S.).
Valdés VJ; Instituto de Fisiología Celular, UNAM, Mexico City (V.J.V., A.S., L.V.).
Sampieri A; Instituto de Fisiología Celular, UNAM, Mexico City (V.J.V., A.S., L.V.).
Reyes-García JG; Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City (J.G.R.-G., F.J.F.-M.).
Carrasco-Portugal MDC; Unidad de Investigación en Farmacología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City (M.C.-P., F.J.F.-M.).
Flores-Murrieta FJ; Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City (J.G.R.-G., F.J.F.-M.).; Unidad de Investigación en Farmacología, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City (M.C.-P., F.J.F.-M.).
Aguilar-Salinas CA; Unidad de Investigación en Enfermedades Metabólicas and Departamento de Endocrinología y Metabolismo, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (F.G.-P., C.A.A.-S.).; Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, N.L. Mexico (C.A.A.-S.).
Vargas-Alarcón G; Departamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City (G.V.-A.).
Shih D; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (D.S., A.J.L., A.H.-V.).
Meikle PJ; Head Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (P.J.M.).
Calkin AC; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (A.C.C., B.G.D.).; Central Clinical School, Monash University, Melbourne, VIC, Australia (A.C.C., B.G.D.).; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC, Australia (A.C.C., B.G.D.).
Drew BG; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia (A.C.C., B.G.D.).; Central Clinical School, Monash University, Melbourne, VIC, Australia (A.C.C., B.G.D.).; Baker Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC, Australia (A.C.C., B.G.D.).
Vaca L; Instituto de Fisiología Celular, UNAM, Mexico City (V.J.V., A.S., L.V.).
Lusis AJ; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (D.S., A.J.L., A.H.-V.).
Huertas-Vazquez A; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (D.S., A.J.L., A.H.-V.).
Villarreal-Molina T; Laboratorio de Enfermedades Cardiovasculares, INMEGEN, Mexico City (L.J.-A., M.D.-P., T.V.-M.).
Canizales-Quinteros S; Unidad de Genómica de Poblaciones Aplicada a la Salud, Facultad de Química, Universidad Nacional Autónoma de México (UNAM)/Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City (P.L.-M., H.V.-R., L.R.M.-K., B.E.L.-C., S.M.-R., M.O.-A., P.L.-M., R.N.-G., S.C.-Q.).
Pokaż więcej
Źródło :
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2021 Sep; Vol. 41 (9), pp. 2494-2508. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms :
Polymorphism, Single Nucleotide*
Cholesterol, HDL/*blood
Coronary Artery Disease/*genetics
Hyperlipoproteinemia Type II/*genetics
Nucleotide Transport Proteins/*genetics
Adult ; Age of Onset ; Animals ; Biomarkers/blood ; Case-Control Studies ; Child ; Coronary Artery Disease/blood ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/epidemiology ; Disease Models, Animal ; Female ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; HEK293 Cells ; Heart Disease Risk Factors ; Humans ; Hyperlipoproteinemia Type II/blood ; Hyperlipoproteinemia Type II/diagnosis ; Hyperlipoproteinemia Type II/epidemiology ; Male ; Mendelian Randomization Analysis ; Mexico/epidemiology ; Mice ; Middle Aged ; Nucleotide Transport Proteins/metabolism ; Phenotype ; Risk Assessment
Czasopismo naukowe
Tytuł :
A 2-year investigation of the impact of the computed tomography-derived fractional flow reserve calculated using a deep learning algorithm on routine decision-making for coronary artery disease management.
Autorzy :
Liu X; Guangdong Academy Research on VR Industry, Foshan University, #18 Jiangwan 1st Road, Foshan, 528000, Guangdong, China.
Mo X; Medical Imaging Center, The First Affiliated Hospital of Jinan University, No 613 Huangpu Dadao West, Guangzhou, 510630, China.; Engineering Research Center of Medical Imaging Artificial Intelligence for Precision Diagnosis and Treatment, No 613 Huangpu Dadao West, Guangzhou, 610630, China.
Zhang H; School of Biomedical Engineering, Sun Yat-sen University, No. 135, Xingang Xi Road, Guangzhou, 510275, China.
Yang G; National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Shi C; Medical Imaging Center, The First Affiliated Hospital of Jinan University, No 613 Huangpu Dadao West, Guangzhou, 510630, China. .; Engineering Research Center of Medical Imaging Artificial Intelligence for Precision Diagnosis and Treatment, No 613 Huangpu Dadao West, Guangzhou, 610630, China. .
Hau WK; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing St., Sha Tin, Hong Kong, SAR, China.
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Sep; Vol. 31 (9), pp. 7039-7046. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/therapy
Coronary Stenosis*/diagnostic imaging
Coronary Stenosis*/therapy
Deep Learning*
Fractional Flow Reserve, Myocardial*
Algorithms ; Computed Tomography Angiography ; Coronary Angiography ; Hemodynamics ; Humans ; Predictive Value of Tests ; Retrospective Studies ; Severity of Illness Index ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Prognostic Impact of Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography.
Autorzy :
Košuta D; Department of Vascular Diseases, 364687Division of Internal Medicine, University Medical Centre of Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Slovenia.
Jug B; Department of Vascular Diseases, 364687Division of Internal Medicine, University Medical Centre of Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Slovenia.
Fras Z; Department of Vascular Diseases, 364687Division of Internal Medicine, University Medical Centre of Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Slovenia.
Pokaż więcej
Źródło :
Angiology [Angiology] 2021 Sep; Vol. 72 (8), pp. 749-753. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article
MeSH Terms :
Computed Tomography Angiography*
Coronary Angiography*
Multidetector Computed Tomography*
Coronary Artery Disease/*diagnostic imaging
Adult ; Aged ; Angina, Unstable/etiology ; Angina, Unstable/mortality ; Angina, Unstable/therapy ; Coronary Artery Disease/complications ; Coronary Artery Disease/mortality ; Coronary Artery Disease/therapy ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Myocardial Revascularization ; Predictive Value of Tests ; Prognosis ; Risk Assessment ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Preoperative plasma biomarkers associated with atrial fibrillation after coronary artery bypass surgery.
Autorzy :
Li XY; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Hou HT; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Chen HX; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Liu XC; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Wang J; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Yang Q; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
He GW; Center for Basic Medical Research and Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Department of Cardiac Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, China; School of Pharmacy, Wannan Medical College, Wuhu, Anhui, China; Department of Surgery, Oregon Health and Science University, Portland, Ore. Electronic address: .
Pokaż więcej
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2021 Sep; Vol. 162 (3), pp. 851-863.e3. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Proteome*
Proteomics*
Atrial Fibrillation/*etiology
Coronary Artery Bypass/*adverse effects
Coronary Artery Disease/*surgery
Aged ; Apolipoprotein C-III/blood ; Atrial Fibrillation/blood ; Atrial Fibrillation/diagnosis ; Biomarkers/blood ; Cholesterol Ester Transfer Proteins/blood ; Chromatography, High Pressure Liquid ; Chromatography, Reverse-Phase ; Coronary Artery Disease/blood ; Coronary Artery Disease/diagnostic imaging ; Enzyme-Linked Immunosorbent Assay ; Glutathione Peroxidase/blood ; Humans ; Male ; Mass Spectrometry ; Middle Aged ; Phospholipid Transfer Proteins/blood ; Predictive Value of Tests ; Preoperative Period ; Prospective Studies ; Reproducibility of Results ; Risk Assessment ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
High Coronary Wall Shear Stress Worsens Plaque Vulnerability: A Systematic Review and Meta-Analysis.
Autorzy :
Bajraktari A; Institute of Public Health and Clinical Medicine, Umea University, Sweden.
Bytyçi I; Institute of Public Health and Clinical Medicine, Umea University, Sweden.; University College, Bardhosh, Kosovo.; Clinic of Cardiology, University Clinical Centre of Kosovo, Prishtina, Kosovo.
Henein MY; Institute of Public Health and Clinical Medicine, Umea University, Sweden.; Molecular and Clinic Research Institute, St George University, London, and Brunel University, United Kingdom.
Pokaż więcej
Źródło :
Angiology [Angiology] 2021 Sep; Vol. 72 (8), pp. 706-714. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Coronary Circulation*
Hemodynamics*
Plaque, Atherosclerotic*
Vascular Remodeling*
Coronary Artery Disease/*physiopathology
Coronary Vessels/*physiopathology
Adult ; Aged ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/pathology ; Coronary Vessels/diagnostic imaging ; Coronary Vessels/pathology ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Risk Assessment ; Risk Factors ; Rupture, Spontaneous ; Stress, Mechanical ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł :
Vitamin D deficiency among Polish patients with angiographically confirmed coronary heart disease.
Autorzy :
Dziedzic EA; Faculty of Medicine, the Lazarski University of Warsaw, Poland.
Gasior JS; Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Poland.
Saniewski T; Department of Internal Medicine, 'Praski' Hospital, Warsaw, Poland.
Dabrowski M; Department of Cardiology, Bielanski Hospital, Warsaw, Poland.
Pokaż więcej
Źródło :
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2021 Aug 16; Vol. 49 (292), pp. 278-282.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/epidemiology
Vitamin D Deficiency*/epidemiology
Aged ; Coronary Angiography ; Female ; Humans ; Male ; Middle Aged ; Poland/epidemiology ; Vitamin D
Czasopismo naukowe
Tytuł :
Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs.
Autorzy :
Kraler S; Center for Molecular Cardiology, University of Zürich, Switzerland (S.K., A.A., G.G.C., T.F.L.).
Libby P; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (P.L.).
Evans PC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom (P.C.E.).
Akhmedov A; Center for Molecular Cardiology, University of Zürich, Switzerland (S.K., A.A., G.G.C., T.F.L.).
Schmiady MO; Clinic for Cardiac Surgery (M.O.S.), University Hospital Zurich, Switzerland.
Reinehr M; University Heart Centre, Institute of Pathology and Molecular Pathology (M.R.), University Hospital Zurich, Switzerland.
Camici GG; Center for Molecular Cardiology, University of Zürich, Switzerland (S.K., A.A., G.G.C., T.F.L.).; Department of Cardiology (G.G.C.), University Hospital Zurich, Switzerland.; Department of Research and Education (G.G.C.), University Hospital Zurich, Switzerland.
Lüscher TF; Center for Molecular Cardiology, University of Zürich, Switzerland (S.K., A.A., G.G.C., T.F.L.).; Royal Brompton and Harefield Hospitals and Imperial College, London, United Kingdom (T.F.L.).
Pokaż więcej
Źródło :
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2021 Aug; Vol. 41 (8), pp. 2237-2251. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronary Artery Bypass*/adverse effects
Plaque, Atherosclerotic*
Vascular Remodeling*
Atherosclerosis/*pathology
Coronary Artery Disease/*surgery
Mammary Arteries/*pathology
Mammary Arteries/*transplantation
Animals ; Atherosclerosis/metabolism ; Atherosclerosis/physiopathology ; Atherosclerosis/therapy ; Coronary Artery Disease/metabolism ; Coronary Artery Disease/pathology ; Coronary Artery Disease/physiopathology ; Health Services Needs and Demand ; Humans ; Mammary Arteries/metabolism ; Mammary Arteries/physiopathology ; Risk Assessment ; Risk Factors ; Treatment Outcome ; Vascular Patency
Czasopismo naukowe
Tytuł :
Patterns and determinants of treatment for coronary artery disease: A cross-sectional study in the Kingdom of Saudi Arabia.
Autorzy :
Al-Ghamdi SH; From the Department of Family and Community Medicine (Al-Ghamdi, AlAjmi); from the College of Medicine (Aldosari), Prince Sattam Bin Abdulaziz University, Al Kharj; and from the Adult Critical Care Medicine Department (Aldosari), Security Forces Hospital Program, Riyadh, Kingdom of Saudi Arabia.
Aldosari KH; From the Department of Family and Community Medicine (Al-Ghamdi, AlAjmi); from the College of Medicine (Aldosari), Prince Sattam Bin Abdulaziz University, Al Kharj; and from the Adult Critical Care Medicine Department (Aldosari), Security Forces Hospital Program, Riyadh, Kingdom of Saudi Arabia.
AlAjmi MM; From the Department of Family and Community Medicine (Al-Ghamdi, AlAjmi); from the College of Medicine (Aldosari), Prince Sattam Bin Abdulaziz University, Al Kharj; and from the Adult Critical Care Medicine Department (Aldosari), Security Forces Hospital Program, Riyadh, Kingdom of Saudi Arabia.
Pokaż więcej
Źródło :
Saudi medical journal [Saudi Med J] 2021 Aug; Vol. 42 (8), pp. 895-902.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/epidemiology
Coronary Artery Disease*/therapy
Percutaneous Coronary Intervention*
Adolescent ; Adult ; Coronary Artery Bypass ; Cross-Sectional Studies ; Humans ; Male ; Risk Factors ; Saudi Arabia/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: An ethnicity-based updated meta-analysis.
Autorzy :
Jafrin S; Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Sonapur 3814, Noakhali, Bangladesh.
Naznin NE; Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Sonapur 3814, Noakhali, Bangladesh.
Reza MS; Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Sonapur 3814, Noakhali, Bangladesh.
Aziz MA; Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Sonapur 3814, Noakhali, Bangladesh.
Islam MS; Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Sonapur 3814, Noakhali, Bangladesh. Electronic address: .
Pokaż więcej
Źródło :
European journal of internal medicine [Eur J Intern Med] 2021 Aug; Vol. 90, pp. 49-65. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/genetics
Stroke*/drug therapy
Stroke*/epidemiology
Stroke*/genetics
Clopidogrel/therapeutic use ; Cytochrome P-450 CYP2C19/genetics ; Ethnic Groups ; Genotype ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic implications of coronary physiological indices in patients with diabetes mellitus.
Autorzy :
Hwang D; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
Zhang J; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
Lee JM; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Doh JH; Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.
Nam CW; Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.
Shin ES; Division of Cardiology, Ulsan Hospital, Ulsan, South Korea and Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Hoshino M; Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Murai T; Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Yonetsu T; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Mejía-Rentería H; Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain.
Kakuta T; Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Escaned J; Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Koo BK; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea; Institute of Aging, Seoul National University, Seoul, Korea. Electronic address: .
Pokaż więcej
Źródło :
Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2021 Aug; Vol. 74 (8), pp. 682-690. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/epidemiology
Coronary Stenosis*
Diabetes Mellitus*/epidemiology
Fractional Flow Reserve, Myocardial*
Coronary Vessels/diagnostic imaging ; Humans ; Microcirculation ; Predictive Value of Tests ; Prognosis
Czasopismo naukowe
Tytuł :
Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial.
Autorzy :
Gouda P; University of Alberta, Mazankowski Heart Institute, 8440 112, St NW Edmonton, Alberta, T6G 2B7, Canada.
Ramasundarahettige C; Mcmaster University, Population Health Research Institute, 237 Barton Street East, Hamilton, Ontario, L8L 2X2, Canada.
Anand S; Mcmaster University, Population Health Research Institute, 237 Barton Street East, Hamilton, Ontario, L8L 2X2, Canada.
Muhlhoffer E; Bayer AG, 51368, Lenerkusen, Germany.
Berkowitz S; Bayer AG, 51368, Lenerkusen, Germany.
Fox KA; University of Edinburgh, Old College, South Bridge, Edinburgh, EH8 9YL, UK.
Eikelboom J; Mcmaster University, Population Health Research Institute, 237 Barton Street East, Hamilton, Ontario, L8L 2X2, Canada.
Welsh R; University of Alberta, Mazankowski Heart Institute, 8440 112, St NW Edmonton, Alberta, T6G 2B7, Canada. Electronic address: .
Pokaż więcej
Źródło :
Atherosclerosis [Atherosclerosis] 2021 Aug; Vol. 331, pp. 38-44. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/epidemiology
Peripheral Arterial Disease*/diagnosis
Peripheral Arterial Disease*/epidemiology
Humans ; Logistic Models ; Lower Extremity ; Risk Factors
Czasopismo naukowe
Tytuł :
Variation of computed tomographic angiography-based fractional flow reserve after transcatheter aortic valve implantation.
Autorzy :
Zhang Y; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Xiong TY; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Li YM; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Huang FY; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Peng Y; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Li Q; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Wei JF; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
He S; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Cao KL; Keya Medical Technology CO. Ltd, Shenzhen, China.
Feng Y; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China.
Xu B; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Mylotte D; Department of Cardiology, University Hospital Galway, Galway, Ireland.
Chen M; Department of Cardiology, West China Hospital, Sichuan University, #37 Guo Xue Alley, Chengdu, 610041, China. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Aug; Vol. 31 (8), pp. 6220-6229. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/surgery
Coronary Stenosis*
Fractional Flow Reserve, Myocardial*
Transcatheter Aortic Valve Replacement*
Computed Tomography Angiography ; Coronary Angiography ; Coronary Vessels/diagnostic imaging ; Hemodynamics ; Humans ; Predictive Value of Tests ; Retrospective Studies ; Severity of Illness Index ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report.
Autorzy :
Seferovic JP; Endocrinology, Diabetes and Metabolic Disorder Clinic, Clinical Center of Serbia, Belgrade, Serbia.
Tesic M; Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Lezaic V; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Nephrology Clinic, Clinical Center of Serbia, Belgrade, Serbia.
Seferovic PM; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Serbian Academy of Sciences and Arts, Belgrade, Serbia.
Lalic NM; Endocrinology, Diabetes and Metabolic Disorder Clinic, Clinical Center of Serbia, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Serbian Academy of Sciences and Arts, Belgrade, Serbia.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 Aug; Vol. 49 (8), pp. 3000605211033177.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Coronary Artery Disease*/complications
Coronary Artery Disease*/diagnostic imaging
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Kidney Diseases*
Percutaneous Coronary Intervention*
Aged ; Contrast Media/adverse effects ; Coronary Angiography ; Creatinine ; Female ; Humans ; Male ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Patient Risk Interpretation of Symptoms Model (PRISM): How Patients Assess Cardiac Risk.
Autorzy :
Kreatsoulas C; Harvard TH Chan School of Public Health, Boston, MA, USA. .; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. .
Taheri C; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Pattathil N; Faculty of Health Sciences, School of Medicine, Queen's University, Kingston, ON, Canada.
Panchal P; Faculty of Health Sciences, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Kakkar T; Public Health Agency of Canada, Ottawa, ON, Canada.
Pokaż więcej
Źródło :
Journal of general internal medicine [J Gen Intern Med] 2021 Aug; Vol. 36 (8), pp. 2205-2211. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/epidemiology
Aged ; Coronary Angiography ; Female ; Heart ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Sex Factors
Czasopismo naukowe
Tytuł :
Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance.
Autorzy :
Li DL; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
Kronenberg MW; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: .
Pokaż więcej
Źródło :
The American journal of medicine [Am J Med] 2021 Aug; Vol. 134 (8), pp. 968-975. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Myocardial Perfusion Imaging*
Coronary Artery Disease/*diagnostic imaging
Cardiac Imaging Techniques ; Coronary Artery Disease/physiopathology ; Coronary Artery Disease/therapy ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Autorzy :
Völz S; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Redfors B; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Angerås O; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Ioanes D; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Odenstedt J; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Koul S; Department of Cardiology, Skåne University Hospital, 22242 Lund, Sweden.
Valeljung I; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Dworeck C; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Hofmann R; Division of Cardiology, Department of Clinical Science and Education, Karolinska Institute, Södersjukhuset, 11861 Stockholm, Sweden.
Hansson E; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital and Institute of Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.
Venetsanos D; Division of Cardiology, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Karolinska Solna, 171 76 Stockholm, Sweden.
Ulvenstam A; Department of Cardiology, Östersund Hospital, 831 83 Östersund, Sweden.
Jernberg T; Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, 182 88 Stockholm, Sweden.
Råmunddal T; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Pétursson P; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Fröbert O; Department of Cardiology, Örebro University, Faculty of Health, 781 85 Örebro, Sweden.
Erlinge D; Department of Cardiology, Skåne University Hospital, 22242 Lund, Sweden.
Jeppsson A; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital and Institute of Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.
Omerovic E; Department of Cardiology, Sahlgrenska University Hospital, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Bruna straket 16, 413 45 Gothenburg, Sweden.
Pokaż więcej
Źródło :
European heart journal [Eur Heart J] 2021 Jul 15; Vol. 42 (27), pp. 2657-2664.
Typ publikacji :
Journal Article
MeSH Terms :
Angioplasty, Balloon, Coronary*
Coronary Artery Disease*/complications
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/surgery
Heart Failure*
Percutaneous Coronary Intervention*
Aged ; Coronary Angiography ; Coronary Artery Bypass ; Female ; Humans ; Male ; Middle Aged ; Registries ; Sweden/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cancer-related vulnerable lesions in patients with stable coronary artery disease.
Autorzy :
Taruya A; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Nakajima Y; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Tanaka A; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: .
Kashiwagi M; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Tanimoto T; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Kuroi A; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Shiono Y; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Shimamura K; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Kubo T; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Sougawa H; Department of Cardiovascular Medicine, Hashimoto Municipal Hospital, Hashimoto, Japan.
Masuno T; Department of Cardiovascular Medicine, Hashimoto Municipal Hospital, Hashimoto, Japan.
Ozaki Y; Department of Cardiovascular Medicine, Shingu Municipal Medical Center, Shingu, Japan.
Satogami K; Department of Cardiovascular Medicine, Shingu Municipal Medical Center, Shingu, Japan.
Ota S; Department of Cardiovascular Medicine, Shingu Municipal Medical Center, Shingu, Japan.
Katayama Y; Department of Cardiovascular Medicine, Shingu Municipal Medical Center, Shingu, Japan.
Ino Y; Department of Cardiovascular Medicine, Shingu Municipal Medical Center, Shingu, Japan.
Hoshiya H; Department of Cardiovascular Medicine, Hashimoto Municipal Hospital, Hashimoto, Japan.
Akasaka T; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2021 Jul 15; Vol. 335, pp. 1-6. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/epidemiology
Neoplasms*/epidemiology
Plaque, Atherosclerotic*
Coronary Angiography ; Coronary Vessels/diagnostic imaging ; Humans ; Predictive Value of Tests ; Prognosis ; Tomography, Optical Coherence
Czasopismo naukowe
Tytuł :
High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease.
Autorzy :
Zuber V; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Gill D; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Ala-Korpela M; Computational Medicine, Faculty of Medicine, University of Oulu & Biocenter Oulu, Oulu, Finland.; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Langenberg C; MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Butterworth A; Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK.; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.; National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK.; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK.; Department of Human Genetics, Wellcome Sanger Institute, Hinxton, UK.
Bottolo L; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Alan Turing Institute, London, UK.
Burgess S; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Department of Public Health and Primary Care, British Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
International journal of epidemiology [Int J Epidemiol] 2021 Jul 09; Vol. 50 (3), pp. 893-901.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronary Artery Disease*/epidemiology
Coronary Artery Disease*/genetics
Mendelian Randomization Analysis*
Apolipoproteins B/genetics ; Bayes Theorem ; Cholesterol, LDL ; Humans ; Lipids ; Risk Factors
Czasopismo naukowe
Tytuł :
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
Autorzy :
Eikelboom JW; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Bosch J; Population Health Research Institute, Hamilton Ontario, Canada; School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
Connolly SJ; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Anand SS; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Berkowitz SD; Bayer US, LLC, Whippany, New Jersey, USA.
Branch KRH; University of Washington Medical Center, Seattle, Washington, USA.
Dagenais GR; Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, Québec, Canada.
Félix C; Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Guzik TJ; Department of Internal and Agricultural Medicine, Jagiellonian University, Collegium Medicum, Krakow, Poland; British Heart Foundation Centre for Cardiovascular Research, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Hart RG; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada.
Maggioni AP; Italian Association of Hospital Cardiologists Research Center, Florence, Italy.
Muehlhofer E; Bayer AG, Wuppertal, Germany.
Sharma M; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Shestakovska O; Population Health Research Institute, Hamilton Ontario, Canada.
Yusuf S; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Jul 06; Vol. 78 (1), pp. 14-23.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Aspirin*/administration & dosage
Aspirin*/adverse effects
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/mortality
Peripheral Arterial Disease*/diagnosis
Peripheral Arterial Disease*/drug therapy
Peripheral Arterial Disease*/mortality
Rivaroxaban*/administration & dosage
Rivaroxaban*/adverse effects
Aged ; Diabetes Mellitus/epidemiology ; Drug Therapy, Combination ; Factor Xa Inhibitors/administration & dosage ; Factor Xa Inhibitors/adverse effects ; Female ; Heart Failure/epidemiology ; Humans ; Male ; Outcome Assessment, Health Care ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Risk Assessment ; Risk Factors ; Severity of Illness Index
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies